To our knowledge, this study represents the first clinical comparative effectiveness study of tirzepatide and semaglutide in adults with overweight or obesity, the researchers reported
electronic health record network comprising 47,199 patients with pre-existing cardiovascular disease who initiated semaglutide
About 68 percent of participants said their HS improved, with 62 percent experiencing fewer flares and 67 percent seeing fewer new HS lesions form while on GLP-1s
Many beginners fall into the trap of buying highly concentrated vials online without understanding how the compound actually behaves in human tissue
At the 17th Annual ODAC Dermatology, Aesthetic and Surgical Conference held January 17-20 in Orlando, FL, Dr
Bibliography For deeper insights, explore these references: Althof S, et al